Russell-Minda Elizabeth, Jutai Jeffrey, Speechley Mark, Bradley Kaitlin, Chudyk Anna, Petrella Robert
Aging, Rehabilitation, and Geriatric Care Research Centre, Lawson Health Research Institute, Ontario, Canada.
J Diabetes Sci Technol. 2009 Nov 1;3(6):1460-71. doi: 10.1177/193229680900300628.
The primary objective of this review was to determine the strength of evidence for the effectiveness of self-monitoring devices and technologies for individuals with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) based on specific health-related outcome measures. Self-monitoring devices included those that assist patients with managing diabetes and preventing cardiovascular complications (CVCs). A secondary objective was to explore issues of feasibility, usability, and compliance among patients and providers.
Study criteria included individuals >or=14 years and youth (7-14 years) with T1DM or T2DM, intervention with a self-monitoring device, assessment of clinical outcomes with the device, literature in English, and >or=10 participants. Relevant published literature was searched from 1985 to 2008. Randomized controlled trials and observational studies were included. Data were extracted for clinical outcomes, feasibility and compliance methods, and results. Selected studies were independently evaluated with a validated instrument for assessing methodological quality.
Eighteen trials were selected. Predominant types of device interventions included self-monitoring of blood glucose, pedometers, and cell phone or wireless technologies. Feasibility and compliance were measured in the majority of studies.
Self-monitoring of blood glucose continues to be an effective tool for the management of diabetes. Wireless technologies can improve diabetes self-care, and pedometers are effective lifestyle modification tools. The results of this review indicate a need for additional controlled trial research on existing and novel technologies for diabetes self-monitoring, on health outcomes associated with diabetes and CVCs, and device feasibility and compliance.
本综述的主要目的是基于特定的健康相关结局指标,确定自我监测设备和技术对1型糖尿病(T1DM)或2型糖尿病(T2DM)患者有效性的证据强度。自我监测设备包括那些协助患者管理糖尿病和预防心血管并发症(CVC)的设备。次要目的是探讨患者和医护人员之间的可行性、易用性和依从性问题。
研究标准包括年龄≥14岁的个体以及患有T1DM或T2DM的青少年(7 - 14岁)、使用自我监测设备进行干预、用该设备评估临床结局、英文文献以及≥10名参与者。检索了1985年至2008年的相关已发表文献。纳入随机对照试验和观察性研究。提取临床结局、可行性和依从性方法及结果的数据。使用经过验证的评估方法质量的工具对所选研究进行独立评估。
选取了18项试验。主要的设备干预类型包括血糖自我监测、计步器以及手机或无线技术。大多数研究测量了可行性和依从性。
血糖自我监测仍然是糖尿病管理的有效工具。无线技术可改善糖尿病自我护理,计步器是有效的生活方式改变工具。本综述结果表明,需要对糖尿病自我监测的现有和新技术、与糖尿病及CVC相关的健康结局以及设备可行性和依从性进行更多的对照试验研究。